Phospholipases A2 and Prostaglandin Formation in Rat Glomerular Mesangial Cells

  • Henk van den Bosch
  • Margriet J. B. M. Vervoordeldonk
  • Rosa M. Sanchéz
  • Josef Pfeilschifter
  • Casper G. Schalkwijk
Chapter
Part of the NATO ASI Series book series (NSSA, volume 266)

Abstract

Phospholipases A2 are believed to play important roles in the production of bioactive mediators by regulating the release of precursors for these compounds from structural membrane phosphoglycerides. It has become clear during the last years that several and distinct cellular phospholipases A2 exist. These can be distinguished in low molecular weight 14 kDa group I (pancreatic-type) and group II (non-pancreatic-type) enzymes and in high molecular weight 85 kDa or cytosolic phospholipase A2. These require Ca2+ for activity, either in their catalytic mechanism as in the case of 14 kDa phospholipases or for translocation from the cytosol to membranes as in the case of cytosolic phospholipase A2. In addition, Ca2+-independent enzymes exist. Each of these phospholipase A2 activities appears to be subject to multiple regulation mechanisms, both at the transcriptional and post-translational level, depending on the cell type and the cell stimulators. This paper summarizes our data on the regulation of phospholipase A2 activities in relation to prostaglandin formation in rat glomerular mesangial cells.

Keywords

Mesangial Cell Dexamethasone Treatment PLA2 Activity Cytosolic Phospholipase cPLA2 Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pfeilschifter, J., Pignat, W., Vosbeck, K. and Märki, F., Biochem. Biophys. Res. Commun. 159 (1989) 385–394.PubMedCrossRefGoogle Scholar
  2. 2.
    Pfeilschifter, J., Pignat, W., Vosbeck, K., Märki, F. and Wiesenberg, I., Biochem. Soc. Trans. 17 (1989) 916–917.Google Scholar
  3. 3.
    Gronich, J.H., Bonventre, J.V. and Nemenoff, R.A., J. Biol. Chem. 263 (1988) 16645–16651.PubMedGoogle Scholar
  4. 4.
    Gronich, J.H., Bonventre, J.V. and Nemenoff, R.A., Biochem. J. 271 (1990) 37–43.PubMedGoogle Scholar
  5. 5.
    De Jong, J.G.N., Amesz, H., Aarsman, A.J., Lenting, H.B.M. and van den Bosch, H., Eur. J. Biochem. 164 (1987) 129–135.PubMedCrossRefGoogle Scholar
  6. 6.
    Schalkwijk, C., Pfeilschifter, J., Märki, F. and van den Bosch, H., Biochem. Biophys. Res. Commun. 174 (1991) 268–275.PubMedCrossRefGoogle Scholar
  7. 7.
    Schalkwijk, C., Pfeilschifter, J., Märki, F. and van den Bosch, H., J. Biol. Chem. 267 (1992) 8846–8851.PubMedGoogle Scholar
  8. 8.
    Hayakawa, M., Kudo, I., Tornita, M., Nojima, S. and Inoue, K., J. Biochem. 104 (1988) 767–772.PubMedGoogle Scholar
  9. 9.
    Ono, T., Tojo, H., Kuramitsu, S., Kagamiyama, H. and Okamoto, M., J. Biol. Chem. 263 (1988) 5732–5738.PubMedGoogle Scholar
  10. 10.
    Van Schaik, R.H.N., Verhoeven, N.M., Neys, F.W., Aarsman, A.J. and van den Bosch, H. Biochim. Biophys. Acta 1169 (1993) 1–11.PubMedCrossRefGoogle Scholar
  11. 11.
    Mizushima, H., Kudo, I., Horigome, K., Murakami, M., Hayakawa, M., Kim, D.-K., Koudo, E., Tornita, M. and Inoue, K., J. Biochem. 105 (1989) 520–525.PubMedGoogle Scholar
  12. 12.
    Kramer, R.M., Hession, C., Johansen, B., Hayes, G., McGray, P., Pinchong Chow, E., Tizard, R. and Pepinsky, R.B., J. Biol. Chem. 264 (1989) 5768–5775.PubMedGoogle Scholar
  13. 13.
    Aarsman, A.J., Leunissen-Bijvelt, J., van den Koedijk, C.D.M.A., Neys, F.W., Verkleij, A.J. and van den Bosch, H., J. Lipid Med. 1 (1989) 49–61.Google Scholar
  14. 14.
    Van den Bosch, H., Aarsman, A.J., van Schaik, R.H.N., Schalkwijk, C.G., Neys, F.W. and Sturk, A., Biochem. Soc. Trans. 18 (1990) 781–785.PubMedGoogle Scholar
  15. 15.
    Vervoordeldonk, M.J.B.M., Schalkwijk, C.G., Römisch, J., Aarsman, A.J. and van den Bosch, H., Biochim. Biophys. Acta, submitted.Google Scholar
  16. 16.
    Sanchez, R.M., Vervoordeldonk, M.J.B.M., Schalkwijk, C.G. and van den Bosch, H., FEBS Lett., in press.Google Scholar
  17. 17.
    Lippincott-Schwarz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L. and Klausner, R.D., Cell 67 (1991) 601–616.CrossRefGoogle Scholar
  18. 18.
    Fishman, P.H. and Curran, P.K., FEBS Lett. 314 (1992) 371–374.PubMedCrossRefGoogle Scholar
  19. 19.
    Flower, R.J., Br. J. Pharmacol. 94 (1988) 987–1015.PubMedCrossRefGoogle Scholar
  20. 20.
    Davidson, F.F. and Dennis, E.A., Biochem. Pharmacol. 38 (1989) 3645–3651.PubMedCrossRefGoogle Scholar
  21. 21.
    Schalkwijk, C., Vervoordeldonk, M., Pfeilschifter, J., Märki, F. and van den Bosch, H., Biochem. Biophys. Res. Commun. 180 (1991) 46–52.PubMedCrossRefGoogle Scholar
  22. 22.
    Mühl, H. Geiger, T., Pignat, W., Märki, F., van den Bosch, H., Cerletti, N., Cox, D., McMaster, G., Vosbeck, K. and Pfeilschifter, J., FEBS Lett. 301 (1992) 190–194.PubMedCrossRefGoogle Scholar
  23. 23.
    Nakano, T., Ohara, O., Teraoka, H. and Arita, H., J. Biol. Chem. 264 (1990) 12745–12748.Google Scholar
  24. 24.
    Massagué, J., Annu. Rev. Cell Biol. 6 (1990) 597–641.PubMedCrossRefGoogle Scholar
  25. 25.
    Schalkwijk, C.G., de Vet, E., Pfeilschifter, J. and van den Bosch, H., Eur. J. Biochem. 210 (1992) 169176.CrossRefGoogle Scholar
  26. 26.
    Pfeilschifter, J., Schalkwijk, C., Briner, V.A. and van den Bosch, H., J. Clin. Invest., in press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Henk van den Bosch
    • 1
  • Margriet J. B. M. Vervoordeldonk
    • 1
  • Rosa M. Sanchéz
    • 1
  • Josef Pfeilschifter
    • 2
  • Casper G. Schalkwijk
    • 1
  1. 1.Center for Biomembranes and Lipid EnzymologyUtrecht UniversityCH UtrechtThe Netherlands
  2. 2.Department of Pharmacology BiocenterUniversity of BaselBaselSwitzerland

Personalised recommendations